This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Calcilytix Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Ali Komeyli
Introduction
Ali Komeyli is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for genetic conditions. His work focuses on innovative formulations that can improve patient outcomes.
Latest Patents
Komeyli holds a patent for "Formulations of triphenyl calcilytic compounds." This patent provides tablet formulations that include a triphenyl calcilytic compound for the treatment of autosomal dominant hypocalcemia (ADH). The compound is represented by a specific formula and includes variations such as solvates, hydrates, and pharmaceutically acceptable salts.
Career Highlights
Komeyli is currently associated with Calcilytix Therapeutics, Inc., where he applies his expertise in pharmaceutical formulations. His innovative approach has led to advancements in the treatment of conditions related to calcium metabolism.
Collaborations
He collaborates with talented professionals in his field, including Uma Sinha and Ananth Sridhar. These partnerships enhance the research and development efforts at Calcilytix Therapeutics, Inc.
Conclusion
Ali Komeyli's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare solutions. His work in developing formulations for treating autosomal dominant hypocalcemia is a testament to his expertise and dedication.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile